Viewing Compound With Targets

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature

Compound Report Overview

Compound Name: BUTOXAMINE
Compound Identifier: 701426
Mol Structure 2D: 701426
Molecular Weight: 267
Formula: C15 H25 N O3
Development Status: Preclinical
SMILES: COc1ccc(OC)c(c1)C(O)C(C)NC(C)(C)C
Activities CAS Curations Identifiers Literature Properties Similarities SMILES Structures Synonyms Targets
Compound Targets
Compound Gene Gene Type View
BUTOXAMINE 168887 amiloride-sensitive cation channel 5, intestinal View
BUTOXAMINE 135381 sodium channel, voltage-gated, type VII, alpha View
BUTOXAMINE 135191 sodium channel, voltage-gated, type I, beta View
BUTOXAMINE 137182 sodium channel, voltage-gated, type IV, alpha polypeptide View
BUTOXAMINE 132900 sodium channel, voltage-gated, type XI, alpha View
BUTOXAMINE 127643 adrenergic receptor, beta 2 View
BUTOXAMINE 153849 sodium channel, nonvoltage-gated 1 alpha View
BUTOXAMINE 153848 sodium channel, nonvoltage-gated 1 beta View
BUTOXAMINE 165452 sodium channel, voltage-gated, type II, beta View
BUTOXAMINE 150734 sodium channel, voltage-gated, type V, alpha polypeptide View
BUTOXAMINE 165421 sodium channel, voltage-gated, type IX, alpha View
BUTOXAMINE 165479 sodium channel, voltage-gated, type 2, alpha 1 polypeptide View
BUTOXAMINE 165775 sodium channel, voltage-gated, type VIII, alpha polypeptide View
BUTOXAMINE 127667 sodium channel, voltage-gated, type 10, alpha polypeptide View
BUTOXAMINE 127751 sodium channel, nonvoltage-gated 1 gamma View
BUTOXAMINE 133117 sodium channel, voltage-gated, type I, alpha View